Pierre V. Trân - Concepedia

Author

Pierre V. Trân

Eli Lilly (United States)ORCID

Also Known As

MD, Pierre V Tran, Pierre V. Tran, Pierre V. Trân

Publications

2.5K

Citations

H-Index

Concepts

All Affiliations

Eli Lilly (United States)McLean Hospital Harvard University

About

Pierre V. Trân is an author at Eli Lilly (United States) specializing in medicine, psychiatry, and schizophrenia.

Top Concepts

#	Concept	H-Index	Publications	Citations
1	Medicine	9	9	1.4K
2	Social Sciences	7	7	1.3K
3	Pharmacology	4	4	876
4	Health Sciences	1	1	71
5	Neurology	1	1	71

Pierre V. Trân

Publications

Citations

H-Index

Page 1

	Year	Citations
Double-Blind Comparison of Olanzapine Versus Risperidone in the Treatment of Schizophrenia and Other Psychotic Disorders Pierre V. Trân, S.H. Hamilton, Amy J. Kuntz, Journal of Clinical Psychopharmacology Other Psychotic DisordersNeuropsychologyPsychotropic MedicationPsychopharmacologyNeuropsychiatry	1997	717
Olanzapine versus haloperidol: acute phase results of the international double-blind olanzapine trial Charles M. Beasley, S.H. Hamilton, A.M. Crawford, European Neuropsychopharmacology PsychiatryPsychotropic MedicationOlanzapine Versus HaloperidolPsychopharmacologySchizophrenia	1997	281
Extrapyramidal Symptoms and Tolerability of Olanzapine Versus Haloperidol in the Acute Treatment of Schizophrenia Pierre V. Trân, Mary Anne Dellva, G.D. Tollefson, The Journal of Clinical Psychiatry	1997	168
Oral olanzapine <i>versus</i> oral haloperidol in the maintenance treatment of schizophrenia and related psychoses Pierre V. Trân, Mary Anne Dellva, Gary D. Tollefson, The British Journal of Psychiatry	1998	136
A Double-Blind, Controlled Comparison of the Novel Antipsychotic Olanzapine versus Haloperidol or Placebo on Anxious and Depressive Symptoms Accompanying Schizophrenia Gary D. Tollefson, T.M. Sanger, Charles M. Beasley, Biological Psychiatry PsychiatryPsychotic DisorderMedicinePsychotropic MedicationPsychopharmacology	1998	135
Sexual Functioning Assessed in 4 Double-Blind Placebo- and Paroxetine-Controlled Trials of Duloxetine for Major Depressive Disorder Pedro L. Delgado, Stephen K. Brannan, Craig Mallinckrodt, The Journal of Clinical Psychiatry	2005	134
The course of depressive symptoms in predicting relapse in schizophrenia: a double-blind, randomized comparison of olanzapine and risperidone Gary D. Tollefson, Scott W. Andersen, Pierre V. Trân Biological Psychiatry PsychiatryPsychotic DisorderPsychotropic MedicationPsychopharmacologySchizophrenia	1999	80
Long-term Maintenance Treatment of Restless Legs Syndrome With Gabapentin Enacarbil: A Randomized Controlled Study Richard Bogan, Michel A. Cramer Bornemann, Clete A. Kushida, Mayo Clinic Proceedings SleepPain DisordersGabapentin EnacarbilLong-term Maintenance TreatmentNeuropharmacology	2010	71
Olanzapine<i>versus</i>haloperidol in the treatment of schizoaffective disorder Pierre V. Trân, Gary D. Tollefson, T.M. Sanger, The British Journal of Psychiatry	1999	69
Switching to Olanzapine From Previous Antipsychotics Chien‐Te Lee, Bernardo Jorge L. Conde, Mahmud Mazlan, The Journal of Clinical Psychiatry	2002	38

Page 1